Publications

Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients

Moltzahn F, Olshen AB, Baehner L, Peek A, Fong L, Stöppler H, Simko J, Hilton JF, Carroll P, Blelloch R.
Cancer Res. 2011 Jan 15;71(2):550-60. doi: 10.1158/0008-5472.CAN-10-1229. Epub 2010 Nov 22.

On the streets of San Francisco: highlights from the ISSCR Annual Meeting 2010

Elefanty AG, Blelloch R, Passegué E, Wernig M, Mummery CL.
Cell Stem Cell. 2010 Oct 8;7(4):443-50. doi: 10.1016/j.stem.2010.09.002.

miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma

Swarbrick A, Woods SL, Shaw A, Balakrishnan A, Phua Y, Nguyen A, Chanthery Y, Lim L, Ashton LJ, Judson RL, Huskey N, Blelloch R, Haber M, Norris MD, Lengyel P, Hackett CS, Preiss T, Chetcuti A, Sullivan CS, Marcusson EG, Weiss W, L'Etoile N, Goga A.

PML-RAR{alpha} and Dnmt3a1 cooperate in vivo to promote acute promyelocytic leukemia

Subramanyam D, Belair CD, Barry-Holson KQ, Lin H, Kogan SC, Passegué E, Blelloch R.
Cancer Res. 2010 Nov 1;70(21):8792-801. doi: 10.1158/0008-5472.CAN-08-4481. Epub 2010 Sep 21. Erratum in: Cancer Res. 2011 Apr 1;71(7):2805.

Pages